Whitney A Spannuth

Summary

Country: USA

Publications

  1. ncbi Inflammatory pseudotumor of pelvic lymph nodes
    Whitney A Spannuth
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA
    Obstet Gynecol 108:779-82. 2006
  2. ncbi A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy
    Whitney A Spannuth
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The University of Alabama at Birmingham, AL 35294, USA
    Gynecol Oncol 104:591-5. 2007

Detail Information

Publications2

  1. ncbi Inflammatory pseudotumor of pelvic lymph nodes
    Whitney A Spannuth
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA
    Obstet Gynecol 108:779-82. 2006
    ..Inflammatory pseudotumor is a rare benign cause of lymphadenopathy previously reported in several anatomic locations that can simulate malignant neoplasm...
  2. ncbi A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy
    Whitney A Spannuth
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The University of Alabama at Birmingham, AL 35294, USA
    Gynecol Oncol 104:591-5. 2007
    ..To determine the response rate, progression-free survival and toxicity associated with weekly topotecan administered to patients with platinum-sensitive recurrent epithelial ovarian (EOC) in the third-line setting...